Literature DB >> 12753650

Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors.

Min Lu1, Fernando Echeverri, Bryan D Moyer.   

Abstract

The mammalian olfactory G-protein coupled receptor family is comprised of hundreds of proteins that mediate odorant binding and initiate signal transduction cascades leading to the sensation of smell. However, efforts to functionally express olfactory receptors and identify specific odorant ligand-olfactory receptor interactions have been severely impeded by poor olfactory receptor surface expression in heterologous systems. Therefore, experiments were performed to elucidate the cellular mechanism(s) responsible for inefficient olfactory receptor cell surface expression. We determined that the mouse odorant receptors mI7 and mOREG are not selected for export from the ER and therefore are not detectable at the Golgi apparatus or plasma membrane. Specifically, olfactory receptors interact with the ER chaperone calnexin, are excluded from ER export sites, do not accumulate in ER-Golgi transport intermediates at 15 degrees C, and contain endoglycosidase H-sensitive oligosaccharides, consistent with olfactory receptor exclusion from post-ER compartments. A labile pool of ER-retained olfactory receptors are post-translationally modified by polyubiquitination and targeted for degradation by the proteasome. In addition, olfactory receptors are sequestered into ER aggregates that are degraded by autophagy. Collectively, these data demonstrate that poor surface expression of olfactory receptors in heterologous cells is attributable to a combination of ER retention due to inefficient folding and poor coupling to ER export machinery, aggregation, and degradation via both proteasomal and autophagic pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753650     DOI: 10.1034/j.1600-0854.2003.00097.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  65 in total

1.  Adenosine A2A receptor is involved in cell surface expression of A2B receptor.

Authors:  Kengo Moriyama; Michail V Sitkovsky
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

3.  Quality control autophagy degrades soluble ERAD-resistant conformers of the misfolded membrane protein GnRHR.

Authors:  Scott A Houck; Hong Yu Ren; Victoria J Madden; Jacob N Bonner; Michael P Conlin; Jo Ann Janovick; P Michael Conn; Douglas M Cyr
Journal:  Mol Cell       Date:  2014-03-27       Impact factor: 17.970

4.  Ric-8B promotes functional expression of odorant receptors.

Authors:  Luiz Eduardo C Von Dannecker; Adriana F Mercadante; Bettina Malnic
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

5.  Visualizing odorant receptor trafficking in living cells down to the single-molecule level.

Authors:  V Jacquier; M Prummer; J-M Segura; H Pick; H Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-15       Impact factor: 11.205

Review 6.  Regulation of G protein-coupled receptor export trafficking.

Authors:  Chunmin Dong; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2006-09-23

Review 7.  Mammalian odorant receptors: functional evolution and variation.

Authors:  Yue Jiang; Hiroaki Matsunami
Journal:  Curr Opin Neurobiol       Date:  2015-02-05       Impact factor: 6.627

Review 8.  Searching for the ligands of odorant receptors.

Authors:  Bettina Malnic
Journal:  Mol Neurobiol       Date:  2007-04       Impact factor: 5.590

9.  Effect of rapamycin on the fate of P23H opsin associated with retinitis pigmentosa (an American Ophthalmological Society thesis).

Authors:  Shalesh Kaushal
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 10.  Trafficking and quality control of the gonadotropin releasing hormone receptor in health and disease.

Authors:  P Michael Conn; Jo Ann Janovick
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.